ProQR Therapeutics N.V. - Ordinary Shares (PRQR) Social Stream
ProQR Therapeutics NV (PRQR) Price Targets From Analysts
Use the tables below to see what analysts covering ProQR Therapeutics NV think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 4 | $33 | $18 | $22.75 | $7.6 | 199.34% |
The Trend in the Analyst Price Target
Over the past 18 months, PRQR's average price target has gone down $0.92.
Over the past 18 months, PRQR's average upside potential has been 308.32%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-07 | 4 | 33.00000 | 18.00000 | 22.75000 | 8.41 | 170.51% |
| 2021-07-02 | 7 | 39.57211 | 17.80745 | 25.34514 | 6.51 | 289.33% |
| 2021-07-02 | 7 | 39.60979 | 17.82441 | 25.36927 | 6.51 | 289.7% |
| 2021-07-02 | 7 | 39.37001 | 17.71650 | 25.21569 | 6.51 | 287.34% |
| 2021-07-02 | 7 | 39.25528 | 17.66488 | 25.14222 | 6.51 | 286.21% |
| 2021-07-02 | 7 | 39.58011 | 17.81105 | 25.35026 | 6.51 | 289.4% |
| 2021-07-02 | 7 | 39.46739 | 17.76033 | 25.27806 | 6.51 | 288.3% |
| 2021-07-02 | 7 | 39.22160 | 17.64972 | 25.12064 | 6.51 | 285.88% |
| 2021-07-02 | 7 | 39.33632 | 17.70135 | 25.19412 | 6.51 | 287.01% |
| 2021-04-15 | 6 | 45.15092 | 18.47088 | 26.67529 | 6.18 | 331.64% |
| 2021-04-15 | 7 | 45.15092 | 18.47088 | 26.67529 | 6.18 | 331.64% |
| 2021-04-15 | 6 | 45.02007 | 18.41735 | 26.59799 | 6.18 | 330.39% |
| 2021-04-15 | 7 | 45.02007 | 18.41735 | 26.59799 | 6.18 | 330.39% |
| 2021-04-15 | 6 | 44.41549 | 18.17002 | 26.24080 | 6.18 | 324.61% |
| 2021-04-15 | 7 | 44.41549 | 18.17002 | 26.24080 | 6.18 | 324.61% |
| 2021-04-15 | 6 | 44.84288 | 18.34486 | 26.49331 | 6.18 | 328.69% |
| 2021-04-15 | 7 | 44.84288 | 18.34486 | 26.49331 | 6.18 | 328.69% |
| 2021-04-15 | 6 | 45.08605 | 18.44434 | 26.63697 | 6.18 | 331.02% |
| 2021-04-15 | 7 | 45.08605 | 18.44434 | 26.63697 | 6.18 | 331.02% |
| 2020-05-13 | NA | 36.27000 | 18.40000 | 23.67000 | NA | NA% |
PRQR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
PRQR's average broker recommendation rating improved by 0.62 over the prior 31 days.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- PRQR has a higher upside potential (average analyst target price relative to current price) than 92.37% of all US stocks.
- ProQR Therapeutics NV's variance in analysts' estimates is less than 14.87% of all US stocks.
- ProQR Therapeutics NV's number of analysts covering the stock is higher than 32.23% of Pharmaceutical Products stocks.
- ProQR Therapeutics NV's average analyst price target is greater than 34.37% of all US stocks.
In the Pharmaceutical Products industry, ABCL, OTIC and RLMD are the three stocks most similar to ProQR Therapeutics NV regarding the price target and analyst recommendation information presented here.
What is the outlook for PRQR? Use POWR Ratings for clearer insight into price direction.